Following success across the UK’s National Health Service identifying breast, ovarian, and colorectal cancers years earlier than traditional methods, Khosla invests to bring to the U.S. Company’s AI ...
C the Signs Ltd. recently received a capital injection of $8 million from Khosla Ventures to expand its AI-powered cancer prediction platform to the U.S. market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results